Presepsin as a Potential Prognostic Marker for Sepsis According to Actual Practice Guidelines

• Published in: Journal of personalized medicine Vol. 11; no. 1; p. 2
• Main Authors: Drăgoescu, Alice Nicoleta, Pădureanu, Vlad, Stănculescu, Andreea Doriana, Chiuțu, Luminița Cristina, Florescu, Dan Nicolae, Gheonea, Ioana Andreea, Pădureanu, Rodica, Stepan, Alex, Streba, Costin Teodor, Drocaș, Andrei Ioan, Ciocâlteu-Ionescu, Adriana Mihaela, Șurlin, Valeriu Marin, Drăgoescu, Octavian Petru
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 22.12.2020
• Subjects: presepsin; septic shock; prognosis; sepsis
• ISSN: 2075-4426; 2075-4426
• DOI: 10.3390/jpm11010002

The 2016 Surviving Sepsis Campaign guidelines define sepsis as life-threatening organ dysfunction caused by a dysregulated host response to infection. This study had the objective of assessing the efficacy of presepsin in the prognosis of sepsis. This was a single-center prospective study, performed in Craiova Emergency Hospital, that included 114 patients admitted in the Intensive Care Unit (ICU) department between 2018 and 2019 fulfilling the sepsis criteria. Including criteria were: age ≥ 18, sepsis diagnosed by the Sequential Organ Failure Assessment (SOFA) score of pulmonary, abdominal, urinary, surgical or unknown origin, as well as lactate levels ≥ 2 mmol/l and need of vasopressors for mean arterial pressure (MAP) ≥ 65 mmHg, despite adequate volume resuscitations for patients with septic shock. Patients younger than 18, pregnant, immunocompromised, or with terminal illnesses were excluded. Based on disease severity, patients were distributed into two study groups: sepsis-76 patients and septic shock-38 patients. As expected, SOFA score and most of its components (PaO /FiO , platelets, and Glasgow Coma Score (GCS)) were significantly modified for patients with septic shock compared to those in the sepsis group and for survivors versus non-survivors. Overall death rate was 34.2%, with a significantly higher value for patients with septic shock (55.3% vs. 23.7%, = 0.035). Sepsis marker presepsin was significantly elevated in all patients (2047 ng/mL) and significantly increased for the septic shock patients (2538 ng/mL, < 0.001) and non-survivors (3138 ng/mL, < 0.001). A significant correlation was identified between the SOFA score and presepsin ( = 0.883, < 0.001). The receiver operating characteristics (ROC)-Area Under Curve (AUC) analysis showed significant prognostic values for presepsin regarding both sepsis severity (AUC = 0.726, 95% confidence interval CI = 0.635-0.806) and mortality risk (AUC = 0.861, 95%CI = 0.784-0.919). In conclusion, under the revised definition of sepsis, presepsin could be a useful marker for prognosis of sepsis severity and mortality risk. Additional data are required to confirm the value of presepsin in sepsis prognosis.